Prof. Dr. Mahmut Emre Yıldırım

Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

Anadolu Kliniği Tıp Bilimleri Dergisi, 2026

DOI 10.21673/anadoluklin.1675424 Texte intégral en libre accèsSource : OpenAlex

Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma

Journal of International Medical Research, 2026

DOI 10.1177/03000605251386599 PMID 41521150 Texte intégral en libre accèsSource : OpenAlex

Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

Clinics and Practice, 2026

DOI 10.3390/clinpract16090158 PMID 42783081 Texte intégral en libre accèsSource : OpenAlex

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020467 PMID 41598406 Texte intégral en libre accèsSource : ORCID

Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study

Cancer Control, 2026

DOI 10.1177/10732748261432273 PMID 41779425 Texte intégral en libre accèsSource : ORCID

Prognostic Factors in Advanced Bladder Cancer: A Real-World Retrospective Analysis

Haydarpaşa Numune medical journal (Online), 2026

DOI 10.14744/hnhj.2026.82997 Texte intégral en libre accèsSource : OpenAlex

KRAS Mutasyonu Saptanmayan Metastatik Kolorektal Kanserli Hastalarda Anti-EGFR Kullanımı-Ulusal Onco-Colon Çalışması Gerçek Yaşam Verleri

DergiPark (Istanbul University), 2025

Source : OpenAlex

The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis

BMC Cancer, 2025

DOI 10.1186/s12885-025-14252-3 PMID 40329228 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study

Medicina, 2025

DOI 10.3390/medicina61010154 PMID 39859134 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of Oncology Pharmacy Practice, 2024

DOI 10.1177/10781552241241004 PMID 38613329 Texte intégral en libre accèsSource : OpenAlex

The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy

Scientific Reports, 2024

DOI 10.1038/s41598-024-63096-7 PMID 38802494 21 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis

Medicina, 2024

DOI 10.3390/medicina60081374 PMID 39202654 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer: Impact of Tumor Ki67 and ER Status

Chemotherapy, 2024

DOI 10.1159/000537874 PMID 38368871 5 citations (Europe PMC) Source : OpenAlex

A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients

Cancers, 2024

DOI 10.3390/cancers16142512 PMID 39061152 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older

Journal of Clinical Medicine, 2024

DOI 10.3390/jcm13206263 PMID 39458213 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?

Medicina, 2024

DOI 10.3390/medicina60081372 PMID 39202652 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy

Cureus, 2024

DOI 10.7759/cureus.63362 PMID 39070363 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

Medicina, 2024

DOI 10.3390/medicina60060951 PMID 38929568 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

Heliyon, 2024

DOI 10.1016/j.heliyon.2024.e25029 PMID 38317875 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

Journal of Oncological Sciences, 2024

DOI 10.37047/jos.2024-102164 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older

2024

DOI 10.20944/preprints202409.0812.v1 Texte intégral en libre accèsSource : ORCID

Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024

DOI 10.1007/s00520-024-08856-x PMID 39251491 Texte intégral en libre accèsSource : Europe PMC

Malignancies in individuals living with HIV/AIDS

Romanian Journal of Infectious Diseases, 2024

DOI 10.37897/rjid.2024.1.10 Texte intégral en libre accèsSource : OpenAlex

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e20512 Texte intégral en libre accèsSource : OpenAlex

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Bursa Uludag University - AVESIS, 2024

Source : OpenAlex

Evaluation of the effectiveness of colorectal cancer screening intervention

Cancer Causes & Control, 2024

DOI 10.1007/s10552-023-01839-z PMID 38172469 Source : OpenAlex

Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience

World journal of urology, 2023

DOI 10.1007/s00345-023-04482-0 PMID 37351618 3 citations (Europe PMC) Source : Europe PMC

Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

Medicina Lithuania, 2023

DOI 10.3390/medicina59030557 PMID 36984558 12 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

Pancreas, 2023

DOI 10.1097/mpa.0000000000002238 PMID 37816170 2 citations (Europe PMC) Source : ORCID

The association of hemoglobin/red blood distribution width with overall survival: a retrospective analysis of melanoma

Esperienze Dermatologiche, 2023

DOI 10.23736/s1128-9155.23.00556-3 1 citation (OpenAlex) Source : OpenAlex

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas

Medicina, 2023

DOI 10.3390/medicina59081472 PMID 37629761 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

Journal of Cancer Research and Therapeutics, 2022

DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Journal of Clinical Oncology, 2022

DOI 10.1200/jco.2022.40.16_suppl.e15562 Source : OpenAlex

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

Anti-Cancer Drugs, 2022

DOI 10.1097/cad.0000000000001310 PMID 35703239 3 citations (Europe PMC) Source : OpenAlex

Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience

Journal of Chemotherapy, 2021

DOI 10.1080/1120009x.2021.1923153 PMID 34032198 6 citations (Europe PMC) Source : OpenAlex

Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/10781552211015762 PMID 33961521 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

Journal of Clinical Oncology, 2021

DOI 10.1200/jco.2021.39.15_suppl.e15561 Source : OpenAlex

Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220924088 PMID 32423326 8 citations (Europe PMC) Source : ORCID

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis

Asia-Pacific Journal of Clinical Oncology, 2021

DOI 10.1111/ajco.13426 PMID 32892496 4 citations (Europe PMC) Source : ORCID

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220951612 PMID 32847482 2 citations (Europe PMC) Source : ORCID

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer

Journal of the College of Physicians and Surgeons Pakistan, 2021

DOI 10.29271/jcpsp.2021.06.651 PMID 34102775 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Monoklonal Antikor VEGF Blokajı Yapan Ajanlar (Bevasizumab,Aflibercept, Ramicirumab)

Turkiye Klinikleri Medical Oncology - Special Topics, 2021

Source : OpenAlex

Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

Current Problems in Cancer, 2020

DOI 10.1016/j.currproblcancer.2020.100670 PMID 33129567 1 citation (Europe PMC) Source : OpenAlex

PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

AYBU AVESIS, 2020

Source : OpenAlex

The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker

Tumor Biology, 2016

DOI 10.1007/s13277-016-5025-y PMID 27067437 20 citations (OpenAlex) Source : OpenAlex

Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.15_suppl.e14651 Source : OpenAlex

Akciğer kanserinde sağkalımı etkileyen klinikopatolojik özellikler

Marmara medical journal, 2015

DOI 10.5472/mmj.2015.03731.1 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Akciğer kanserinde sağkalımı etkileyen klinikopatolojik özellikler

Kocaeli Üniversitesi - AVESİS, 2015

DOI 10.5472/mmj.2015.03829.1 Source : OpenAlex

Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment

Biomarkers, 2012

DOI 10.3109/1354750x.2012.709882 PMID 22889408 17 citations (Europe PMC) Source : OpenAlex

Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma

Leukemia Research, 2010

DOI 10.1016/j.leukres.2010.02.013 PMID 20219245 5 citations (Europe PMC) Source : OpenAlex